NP3 A COST-UTILITY MODEL OF TREATMENT OF NEWLY DIAGNOSED...

NP3 A COST-UTILITY MODEL OF TREATMENT OF NEWLY DIAGNOSED EPILEPSY IN GERMANY COMPARING TOPIRAMATE, CARBAMAZEPINE AND VALPROATE

E Remák, B Steinhoff
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65684-7
File:
PDF, 61 KB
english, 2004
Conversion to is in progress
Conversion to is failed